For: | He XY, Bai Y. Acute thrombocytopenia after anticoagulation with rivaroxaban: A case report. World J Clin Cases 2020; 8(5): 928-931 [PMID: 32190629 DOI: 10.12998/wjcc.v8.i5.928] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i5/928.htm |
Number | Citing Articles |
1 |
B. A. Tatarsky, N. V. Kazennova. Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review. Rational Pharmacotherapy in Cardiology 2022; 18(5): 600 doi: 10.20996/1819-6446-2022-10-06
|
2 |
|
3 |
Jan Steffel, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A John Camm, Hein Heidbüchel, Gregory Y H Lip, Thomas Deneke, Nikolaos Dagres, Giuseppe Boriani, Tze-Fan Chao, Eue-Keun Choi, Mellanie True Hills, Itamar de Souza Santos, Deirdre A Lane, Dan Atar, Boyoung Joung, Oana Maria Cole, Mark Field. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Europace 2021; 23(10): 1612 doi: 10.1093/europace/euab065
|
4 |
Twinkle Pawar, Yash Gupte, Sourav Chaturvedi, Anusha Gupta, Sourya Acharya. Rivaroxaban Causing Thrombocytopenia in a Case of Deep Vein Thrombosis (DVT). Journal of Evolution of Medical and Dental Sciences 2021; 10(32): 2687 doi: 10.14260/jemds/2021/548
|
5 |
Seohyun (Claudia) Choi, Danielle Tompkins, Jessica Wilczynski, Caitlin E. Kulig. . Side Effects of Drugs Annual 2021; 43: 393 doi: 10.1016/bs.seda.2021.08.009
|
6 |
Mehdi Salimi, Foroud Shahbazi. Severe and Prolonged Thrombocytopenia Following Heparin and Apixaban
Use: A Case Report and Literature Review. Current Drug Therapy 2024; 19(5): 503 doi: 10.2174/1574885519666230825153414
|
7 |
Jingying Wu, Jianru Wu, Biyu Tang, Xinru Wang, Fenfang Wei, Yi Zhang, Limin Li, Hongqiao Li, Bei Wang, Wenyu Wu, Xiang Hong. Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1399172
|